Literature DB >> 25208817

Is there any effect of lower extremity deep vein thrombosis which proven by Doppler ultrasonography on cancer recurrence in patients with stage III colon cancer? A study of the Turkish Descriptive Oncological Researches Group.

Ozgur Tanriverdi1, Birdal Yildirim, Suha Gul, Esin Cevik, Tulay Akman, Suna Cokmert, Kezban Nur Pilanci, Nilufer Avci, Cetin Ordu, Sabri Barutca.   

Abstract

This study aimed to determine the predictive value of lower extremity deep vein thrombosis (LE-DVT) on first cancer recurrence in patients with stage III colon cancer. A total of 113 eligible patients with stage III colon cancer were divided into two groups according to whether they had LE-DVT. LE-DVT was detected in 29 (26%) patients. Presence of recurrence with distant metastasis had a significant positive correlation with baseline platelet count, baseline mean platelet volume, and the presence of lower extremity deep vein thrombosis. It was concluded that the relation between disease progression and the presence of LE-DVT in stage III colon cancer is independent of other study variables (P=0.031; OR=4.27; 95% CI 1.89-6.71). We hypothesized that the presence of LE-DVT in patients with stage III colon cancer may predict to early cancer recurrence with distant metastasis.

Entities:  

Mesh:

Year:  2014        PMID: 25208817     DOI: 10.1007/s12032-014-0215-1

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  14 in total

Review 1.  The risk of venous thromboembolism is increased throughout the course of malignant glioma: an evidence-based review.

Authors:  L C Marras; W H Geerts; J R Perry
Journal:  Cancer       Date:  2000-08-01       Impact factor: 6.860

2.  Mean platelet volume is increased in patients with deep vein thrombosis.

Authors:  Mehmet Gulcan; Ercan Varol; Mustafa Etli; Fatih Aksoy; Mustafa Kayan
Journal:  Clin Appl Thromb Hemost       Date:  2011-11-22       Impact factor: 2.389

Review 3.  Deep vein thrombosis in cancer: the scale of the problem and approaches to management.

Authors:  A Falanga; L Zacharski
Journal:  Ann Oncol       Date:  2005-03-31       Impact factor: 32.976

Review 4.  Venous thromboembolism in the patient with cancer: focus on burden of disease and benefits of thromboprophylaxis.

Authors:  Gary H Lyman
Journal:  Cancer       Date:  2010-11-08       Impact factor: 6.860

5.  Prognosis of cancers associated with venous thromboembolism.

Authors:  H T Sørensen; L Mellemkjaer; J H Olsen; J A Baron
Journal:  N Engl J Med       Date:  2000-12-21       Impact factor: 91.245

6.  An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study.

Authors:  M M Samama
Journal:  Arch Intern Med       Date:  2000 Dec 11-25

Review 7.  Cancer and thromboembolic disease: pathogenic mechanisms.

Authors:  Agnes Y Lee
Journal:  Cancer Treat Rev       Date:  2002-06       Impact factor: 12.111

Review 8.  Venous thromboembolism and cancer: risks and outcomes.

Authors:  Agnes Y Y Lee; Mark N Levine
Journal:  Circulation       Date:  2003-06-17       Impact factor: 29.690

9.  Deep venous thrombosis during therapy for Hodgkin's disease.

Authors:  E J Seifter; R C Young; D L Longo
Journal:  Cancer Treat Rep       Date:  1985-09

10.  Early changes in the haemostatic and procoagulant systems after chemotherapy for breast cancer.

Authors:  C C Kirwan; G McDowell; C N McCollum; S Kumar; G J Byrne
Journal:  Br J Cancer       Date:  2008-09-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.